Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has gained more than 14.72% over the past month, and Wall Street expects more ...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has gained more than 15% over the past month, mainly driven by the stock’s inclusion in the Russell 3000 index and strong Q1 2026 earnings.

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” ...

View Ironwood Pharmaceuticals, Inc. Class A IRWD stock quote prices, financial information, real-time forecasts, and company news from CNN.

Brown Advisory, an investment management company, released its “Brown Large-Cap Growth Strategy” for the first-quarter 2026 investor letter. A copy of the letter is available to download here.

Shares of Collegium Pharmaceutical COLL have gained around 12% over the past three months, driven by growing investor ...

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company’s lead antibiotic candidate is ...

BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders.

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today ...

Aclaris, Collegium, and Intra-Cellular lead the industry in revenue growth Noah has about a year of writing experience. He's worked on his investing website dealing with topics such as the stock ...